Literature DB >> 19642867

Specific induction of migration and invasion of pancreatic carcinoma cells by RhoC, which differs from RhoA in its localisation and activity.

Karin-Almut Dietrich1, Rene Schwarz, Martina Liska, Stefanie Grass, Andre Menke, Michael Meister, Gesa Kierschke, Claudia Längle, Felicitas Genze, Klaudia Giehl.   

Abstract

RhoA and RhoC are highly related Rho GTPases, but differentially control cellular behaviour. We combined molecular, cellular, and biochemical experiments to characterise differences between these highly similar GTPases. Our findings demonstrate that enhanced expression of RhoC results in a striking increase in the migration and invasion of pancreatic carcinoma cells, whereas forced expression of RhoA decreases these actions. These isoform-specific functions correlate with differences in the cellular activity of RhoA and RhoC in human cells, with RhoC being more active than RhoA in activity assays and serum-response factor-dependent gene transcription. Subcellular localisation studies revealed that RhoC is predominantly localised in the membrane-containing fraction, whereas RhoA is mainly localised in the cytoplasmic fraction. These differences are not mediated by a different interaction with RhoGDIs. In vitro GTP/GDP binding analyses demonstrate different affinity of RhoC for GTP[S] and faster intrinsic and guanine nucleotide exchange factor (GEF)-stimulated GDP/GTP exchange rates compared to RhoA. Moreover, the catalytic domains of SopE and Dbs are efficacious GEFs for RhoC. mRNA expression of RhoC is markedly enhanced in advanced pancreatic cancer stages, and thus the differences discovered between RhoA and RhoC might provide explanations for their different influences on cell migration and tumour invasion.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19642867     DOI: 10.1515/BC.2009.110

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  17 in total

Review 1.  Small Rho GTPases in the control of cell shape and mobility.

Authors:  Arun Murali; Krishnaraj Rajalingam
Journal:  Cell Mol Life Sci       Date:  2013-11-26       Impact factor: 9.261

2.  Cyclic AMP regulates the migration and invasion potential of human pancreatic cancer cells.

Authors:  Noah P Zimmerman; Ishan Roy; Andrew D Hauser; Jessica M Wilson; Carol L Williams; Michael B Dwinell
Journal:  Mol Carcinog       Date:  2013-09-24       Impact factor: 4.784

Review 3.  Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease.

Authors:  Behzad Yeganeh; Emilia Wiechec; Sudharsana R Ande; Pawan Sharma; Adel Rezaei Moghadam; Martin Post; Darren H Freed; Mohammad Hashemi; Shahla Shojaei; Amir A Zeki; Saeid Ghavami
Journal:  Pharmacol Ther       Date:  2014-02-26       Impact factor: 12.310

4.  Diverse roles for the paxillin family of proteins in cancer.

Authors:  Nicholas O Deakin; Jeanine Pignatelli; Christopher E Turner
Journal:  Genes Cancer       Date:  2012-05

5.  The MLK-related kinase (MRK) is a novel RhoC effector that mediates lysophosphatidic acid (LPA)-stimulated tumor cell invasion.

Authors:  Olga Korkina; Zhiwan Dong; Allison Marullo; Gregg Warshaw; Marc Symons; Rosamaria Ruggieri
Journal:  J Biol Chem       Date:  2013-01-14       Impact factor: 5.157

6.  RhoC regulates the proliferation of gastric cancer cells through interaction with IQGAP1.

Authors:  Yan Wu; Yan Tao; Yongchang Chen; Wenrong Xu
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

7.  The RhoGEF TEM4 Regulates Endothelial Cell Migration by Suppressing Actomyosin Contractility.

Authors:  Natalia Mitin; Kent L Rossman; Rachel Currin; Sandeep Anne; Thomas W Marshall; James E Bear; Victoria L Bautch; Channing J Der
Journal:  PLoS One       Date:  2013-06-18       Impact factor: 3.240

8.  Rac1 activation inhibits E-cadherin-mediated adherens junctions via binding to IQGAP1 in pancreatic carcinoma cells.

Authors:  Beatrix Hage; Katrin Meinel; Iris Baum; Klaudia Giehl; Andre Menke
Journal:  Cell Commun Signal       Date:  2009-09-08       Impact factor: 5.712

9.  RhoC impacts the metastatic potential and abundance of breast cancer stem cells.

Authors:  Devin T Rosenthal; Jie Zhang; Liwei Bao; Lian Zhu; Zhifen Wu; Kathy Toy; Celina G Kleer; Sofia D Merajver
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

10.  Src-mediated phosphorylation of the tyrosine phosphatase PRL-3 is required for PRL-3 promotion of Rho activation, motility and invasion.

Authors:  James J Fiordalisi; Brian J Dewar; Lee M Graves; James P Madigan; Adrienne D Cox
Journal:  PLoS One       Date:  2013-05-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.